Transforming
Lifesciences with
Artificial Intelligence

Discover how a leading global MedTech company transformed its ESG strategy using AI-powered insights from Vamstar. This case study explores how the company increased tender visibility by 500%, improved margins by 6-9%, and positioned itself as an industry leader in sustainability. Learn how AI-driven data analysis, real-time ESG tracking, and proactive engagement strategies enabled the company to overcome fragmented processes and gain a competitive edge in the rapidly evolving European market.

Discover how AI solutions from Vamstar can help pharmaceutical companies like Bristol Myers Squibb offset revenue losses due to loss of exclusivity (LoE). This article explores how Vamstar’s predictive market analytics, intelligent procurement tools, and portfolio optimization capabilities empower pharma firms to sustain growth, enhance strategic decisions, and remain competitive against generics. Learn how integrating AI tools can transform LoE challenges into opportunities for innovation and market expansion, as demonstrated by Bristol Myers Squibb’s proactive market strategies

Discover how AI is revolutionising the generics pharmaceutical industry with advanced pricing strategies. Vamstar’s AI-driven Pricing Co-Pilot is setting new standards, transforming how companies approach tender pricing and bidding. Learn about the tangible benefits of integrating AI into your pricing processes, including improved accuracy, increased efficiency, and enhanced profitability. Embrace the future of pharma with AI-powered solutions that promise to refine decision-making and boost competitive advantage.

A leading international MedTech company aimed to improve market visibility and strategic decision-making. Vamstar implemented an AI-powered data orchestration engine, providing comprehensive analysis of tender data and market insights. This transformation enhanced the client’s understanding of market trends and enabled targeted strategies for product introduction and competitive differentiation. Key outcomes included a 4.5% improvement in margins and a 9.2% increase in revenues, demonstrating the significant impact of AI in driving growth and profitability in the MedTech sector.

Overcome Global Market Challenges through Data-Driven Strategies.

A global manufacturer of medical devices and consumables needed to evaluate how emerging ESG (Environmental, Social, and Governance) requirements would impact product marketability across the EU4, UK, and Nordics. Seeking to better understand market risks and opportunities, the client approached Vamstar for insights into differentiation strategies to expand market share.

MedTech Europe engaged Vamstar to conduct a thorough examination of ESG criteria adoption within European MedTech tenders. Leveraging advanced natural language processing and machine learning technologies, Vamstar analyzed over 15,000 tender documents. This comprehensive study provided insights into the increasing importance of ESG factors, identifying growth in ESG weightage from less than 5% in 2020 to 7.3% in 2022, and highlighting best practices that foster effective ESG integration. The analysis also delved into the specific language used in tenders to articulate ESG expectations, offering strategic guidance for enhancing sustainability in procurement processes.

A leading pharmaceutical company with a robust international presence and growing operations in Europe found itself grappling with increased competition in the generics market, particularly in tenders following Loss of Exclusivity (LoE), where market prices plummeted by up to 95%.

In the realm of healthcare, the spectrum of medical supplies is vast, encompassing everything from surgical instruments to bandages, playing a crucial role in the operations of healthcare facilities. Accurate classification, naming, and coding of these supplies are paramount for various functions, including sourcing, tracking, billing, ordering, inventory management, and most importantly, ensuring patient safety.